PEMPHIGUS, Medicine, vol.32, issue.1, pp.1-123, 1953. ,
DOI : 10.1097/00005792-195302000-00001
Pemphigoid diseases, The Lancet, vol.381, issue.9863, pp.320-352, 2013. ,
DOI : 10.1016/S0140-6736(12)61140-4
Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment, American Journal of Clinical Dermatology, vol.231, issue.2, pp.513-541, 2017. ,
DOI : 10.1159/000381143
Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management, Clinical Reviews in Allergy & Immunology, vol.138, issue.365???372, pp.26-51, 2018. ,
DOI : 10.1046/j.1365-2133.1998.02167.x
Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome., Journal of Clinical Investigation, vol.86, issue.4, pp.1088-9410, 1172. ,
DOI : 10.1172/JCI114812
URL : http://www.jci.org/articles/view/114812/files/pdf
Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting, J Immunol, vol.136, pp.1231-1236, 1986. ,
Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases., Journal of Clinical Investigation, vol.83, issue.5, pp.1443-1451, 1989. ,
DOI : 10.1172/JCI114036
URL : http://www.jci.org/articles/view/114036/files/pdf
Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases, Experimental Dermatology, vol.228, issue.Pt 17, pp.1154-62, 2017. ,
DOI : 10.1111/j.0022-202X.2005.23702.x
BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid, Frontiers in Immunology, vol.35, 2017. ,
DOI : 10.1007/s10067-016-3354-2
Bullous pemphigoid and herpes gestationis autoantibodies recognize a common noncollagenous site on the BP180 ectodomain, J Immunol, vol.151, pp.5742-50, 1993. ,
DOI : 10.1016/0923-1811(93)90940-q
IgG Autoantibodies from Bullous Pemphigoid (BP) Patients Bind Antigenic Sites on Both the Extracellular and the Intracellular Domains of the BP Antigen 180, Journal of Investigative Dermatology, vol.112, issue.2, pp.141-148, 1999. ,
DOI : 10.1046/j.1523-1747.1999.00497.x
Severity and Phenotype of Bullous Pemphigoid Relate to Autoantibody Profile Against the NH2- and COOH-Terminal Regions of the BP180 Ectodomain, Journal of Investigative Dermatology, vol.119, issue.5, pp.1065-73, 2002. ,
DOI : 10.1046/j.1523-1747.2002.19529.x
Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid, Clinical Immunology, vol.128, issue.3, pp.415-441, 2008. ,
DOI : 10.1016/j.clim.2008.04.012
Enzyme-linked immunosorbent assay for the combination of Frontiers in Immunology | www.frontiersin, Article, vol.9, issue.570, 2018. ,
Usefulness of BP230 and BP180-NC16a Enzyme-Linked Immunosorbent Assays in the Initial Diagnosis of Bullous Pemphigoid, Archives of Dermatology, vol.147, issue.3, pp.286-91, 2011. ,
DOI : 10.1001/archdermatol.2011.23
URL : https://hal.archives-ouvertes.fr/hal-00584055
Clinical and Immunologic Factors Associated With Bullous Pemphigoid Relapse During the First Year of Treatment, JAMA Dermatology, vol.150, issue.1, pp.25-33, 2014. ,
DOI : 10.1001/jamadermatol.2013.5757
URL : http://archderm.jamanetwork.com/data/journals/derm/929683/doi130040.pdf
Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180???kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins, British Journal of Dermatology, vol.109, issue.3, pp.365-70, 1998. ,
DOI : 10.1007/s004030050093
Epidermolysis bullosa acquisita: Autoimmunity to anchoring fibril collagen, Autoimmunity, vol.83, issue.1, pp.91-101, 2011. ,
DOI : 10.1111/1523-1747.ep12261694
URL : http://europepmc.org/articles/pmc3411315?pdf=render
Epidermolysis Bullosa Acquisita: A Retrospective Clinical Analysis of 30 Cases, Acta Dermato Venereologica, vol.91, issue.3, pp.307-319, 2011. ,
DOI : 10.2340/00015555-1065
URL : https://www.medicaljournals.se/acta/content_files/download.php?doi=10.2340/00015555-1065
Clinical Presentation, Pathogenesis, Diagnosis, and Treatment of Epidermolysis Bullosa Acquisita, ISRN Dermatology, vol.89, issue.5, p.812029, 2013. ,
DOI : 10.1016/j.jaad.2006.05.057
URL : http://downloads.hindawi.com/archive/2013/812029.pdf
In vitro and in vivo models to investigate the pathomechanisms and novel treatments for pemphigoid diseases, Experimental Dermatology, vol.131, issue.12, pp.1163-70, 2017. ,
DOI : 10.1038/jid.2010.248
URL : http://onlinelibrary.wiley.com/doi/10.1111/exd.13415/pdf
Mechanisms of Autoantibody-Induced Pathology, Frontiers in Immunology, vol.34, 2017. ,
DOI : 10.1016/j.autrev.2012.07.005
URL : http://journal.frontiersin.org/article/10.3389/fimmu.2017.00603/pdf
Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model, Journal of Autoimmunity, vol.31, issue.4, pp.331-339, 2008. ,
DOI : 10.1016/j.jaut.2008.08.009
URL : http://europepmc.org/articles/pmc2642586?pdf=render
Tight Clustering of Extracellular BP180 Epitopes Recognized by Bullous Pemphigoid Autoantibodies, Journal of Investigative Dermatology, vol.109, issue.4, pp.573-582, 1997. ,
DOI : 10.1111/1523-1747.ep12337492
URL : https://doi.org/10.1111/1523-1747.ep12337492
Serum Levels of Autoantibodies to BP180 Correlate With Disease Activity in Patients With Bullous Pemphigoid, Archives of Dermatology, vol.136, issue.2, 2000. ,
DOI : 10.1001/archderm.136.2.174
URL : http://archderm.jamanetwork.com/data/journals/derm/4635/dst9032.pdf
Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2, J Invest Dermatol, vol.110, pp.282-288, 1998. ,
Risk Factors for Relapse in Patients With Bullous Pemphigoid in Clinical Remission, Archives of Dermatology, vol.145, issue.5, pp.537-4253, 2009. ,
DOI : 10.1001/archdermatol.2009.53
URL : https://hal.archives-ouvertes.fr/hal-00396992
A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized Study, Journal of Investigative Dermatology, vol.129, issue.7, pp.1681-7412, 2008. ,
DOI : 10.1038/jid.2008.412
URL : https://hal.archives-ouvertes.fr/hal-00396990
A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid, New England Journal of Medicine, vol.346, issue.5, pp.321-328, 2002. ,
DOI : 10.1056/NEJMoa011592
Re-evaluation of the natural course of bullous pemphigoid. A prospective study, International Journal of Dermatology, vol.282, issue.715, 1999. ,
DOI : 10.1007/BF00371640
Variation of the epidermal expression of glucocorticoid receptor-beta as potential predictive marker of bullous pemphigoid outcome, Experimental Dermatology, vol.139, issue.12, pp.1261-1267, 2017. ,
DOI : 10.1016/j.jaci.2016.08.012
Anti-BP180 NC16A IgG titres as an indicator of disease activity and outcome in Asian patients with bullous pemphigoid, Ann Acad Med Singapore, vol.44, pp.119-145, 2015. ,
Evaluation of Clinical Criteria for Diagnosis of Bullous Pemphigoid, Archives of Dermatology, vol.134, issue.9, pp.1075-80, 1998. ,
DOI : 10.1001/archderm.134.9.1075
URL : http://archderm.jamanetwork.com/data/journals/derm/4618/dst8011.pdf
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts, Journal of the American Academy of Dermatology, vol.66, issue.3, pp.479-85, 2012. ,
DOI : 10.1016/j.jaad.2011.06.032
URL : http://europepmc.org/articles/pmc3883429?pdf=render
Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti-type VII collagen autoantibodies: an Italian multicentre study, British Journal of Dermatology, vol.62, issue.1, pp.80-84, 2013. ,
DOI : 10.1111/j.1468-3083.2012.04617.x
BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid, Journal of Dermatological Science, vol.30, issue.3, pp.224-256, 2002. ,
DOI : 10.1016/S0923-1811(02)00109-3
Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid, Journal of Dermatological Science, vol.41, issue.1, 2006. ,
DOI : 10.1016/j.jdermsci.2005.11.002
Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases, BMC Immunology, vol.13, issue.1, pp.16-26, 2012. ,
DOI : 10.1186/1471-2172-13-16
URL : https://bmcimmunol.biomedcentral.com/track/pdf/10.1186/1471-2172-13-16?site=bmcimmunol.biomedcentral.com
Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA), Journal of the American Academy of Dermatology, vol.74, issue.6, pp.1166-72, 2016. ,
DOI : 10.1016/j.jaad.2016.01.005
Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis, British Journal of Dermatology, vol.77, issue.6, pp.1683-92, 2017. ,
DOI : 10.1046/j.1365-2133.2002.04863.x
Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody, Frontiers in Immunology, vol.26, p.479, 2018. ,
DOI : 10.1111/exd.13446
Demonstration of Epitope-Spreading Phenomena in Bullous Pemphigoid: Results of a Prospective Multicenter Study, Journal of Investigative Dermatology, vol.131, issue.11, pp.2271-80, 2011. ,
DOI : 10.1038/jid.2011.180
Epitope Spreading: Lessons From Autoimmune Skin Diseases, Journal of Investigative Dermatology, vol.110, issue.2, 1998. ,
DOI : 10.1046/j.1523-1747.1998.00107.x
URL : https://doi.org/10.1046/j.1523-1747.1998.00107.x
Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome, Scientific Reports, vol.134, issue.1, 2015. ,
DOI : 10.1001/archderm.134.9.1075
Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes, Journal of Allergy and Clinical Immunology, vol.139, issue.3, pp.863-72, 2016. ,
DOI : 10.1016/j.jaci.2016.08.012
URL : https://hal.archives-ouvertes.fr/hal-01754072
Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome, Scientific Reports, vol.138, issue.1, p.4833, 2017. ,
DOI : 10.1016/j.annder.2011.01.009
URL : https://www.nature.com/articles/s41598-017-04687-5.pdf
Biomarkers related to bullous pemphigoid activity and outcome, Experimental Dermatology, vol.97, issue.Pt 3, pp.1240-1247, 2017. ,
DOI : 10.1016/j.cyto.2017.05.014
URL : http://onlinelibrary.wiley.com/doi/10.1111/exd.13459/pdf
Tissue resident regulatory T cells: novel therapeutic targets for human disease, Cellular & Molecular Immunology, vol.480, issue.5, pp.543-52, 2015. ,
DOI : 10.1038/nature09114
URL : http://www.nature.com/cmi/journal/v12/n5/pdf/cmi201523a.pdf
T regulatory cells and other lymphocyte subsets in patients with bullous pemphigoid, Clinical and Experimental Dermatology, vol.119, issue.6, pp.632-639, 2017. ,
DOI : 10.1046/j.1523-1747.2002.19529.x
Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid, Journal of the European Academy of Dermatology and Venereology, vol.10, issue.2, pp.222-252, 2014. ,
DOI : 10.1016/j.autrev.2011.05.004
URL : https://iris.unito.it/bitstream/2318/142764/4/142764_4aperto.pdf
Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases, Frontiers in Immunology, vol.10, 2017. ,
DOI : 10.1038/nrrheum.2014.105
URL : https://www.frontiersin.org/articles/10.3389/fimmu.2017.01628/pdf
BP180- and BP230-specific IgG autoantibodies in pruritic disorders of the elderly: a preclinical stage of bullous pemphigoid?, British Journal of Dermatology, vol.9, issue.2, pp.212-221, 2014. ,
DOI : 10.1111/j.1365-2230.1984.tb00860.x
Innate Immune Cell???Produced IL-17 Sustains Inflammation in Bullous Pemphigoid, Journal of Investigative Dermatology, vol.134, issue.12, pp.2908-2925, 2014. ,
DOI : 10.1038/jid.2014.263
Lesional Th17 cells and regulatory T cells in bullous pemphigoid, Experimental Dermatology, vol.18, issue.12, 2011. ,
DOI : 10.1111/j.1600-0625.2006.00522.x
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0625.2011.01378.x/pdf
Cytokines and bullous pemphigoid, Eur Cytokine Netw, vol.10, pp.123-157, 1999. ,
Increased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activity, Journal of the European Academy of Dermatology and Venereology, vol.298, issue.1, pp.11-16, 1999. ,
DOI : 10.1007/s004030050259
Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity, British Journal of Dermatology, vol.90, issue.4, pp.611-4533, 1998. ,
DOI : 10.1016/0167-5699(93)90230-I
Clinical and immunological features and outcome of anti-p200 pemphigoid, British Journal of Dermatology, vol.34, issue.4, pp.776-81, 2016. ,
DOI : 10.1111/j.1346-8138.2007.00208.x
New insights into pemphigoid diseases, Experimental Dermatology, vol.18, issue.12, pp.1151-1154, 2017. ,
DOI : 10.1111/j.1600-0625.2009.00934.x